Welcome to QCancer®-2016

Welcome to the QCancer®-2016 site.

This website is primarily intended for doctors and nurses working in general practice and for academics who are interest in the underlying research. Patients are welcome to read this information and use the calculator together with their doctor so that any symptoms or concerns can be addressed within a health care setting. All medical decisions need to be taken by a patient in consultation with their doctor. The authors and the sponsors accept no responsibility for clinical use or misuse of this score.

QCancer® works out the risk of a patient having a current but as yet undiagnosed cancer taking account of their risk factors and current symptoms. It does not give a diagnosis of cancer, but a risk.

The QCancer® algorithms have been developed by Julia Hippisley-Cox and Carol Coupland and are based on routinely collected data from many thousands of GPs across the country who have freely contributed data to the QResearch database for medical research.

QCancer® has been developed for the UK population, and is intended for use in the UK.

The science underpinning the new QCancer®-2013 equations has been published in January 2013 edition of the BJGP. The algorithms are updated and recalibrated anually, and this site implements the 2016 update.

There are two calculators, one for men and one for women:

The QCancer® scores:

Some useful documents:

QCancer implemented in EMIS Web

We are delighted that EMIS has finished development work to fully integrate QCancer within EMIS Web. We have worked closely with EMIS and Macmillan Cancer Support on their implementation.

If you are an EMIS customer, you can find further information on their implementation of QCancer within EMIS Web at the EMIS Support centre:

The Macmillan CDS tool implemented by (BMJ) Informatica

For background to this product, please see Macmillan's web site.

Informatica Systems (formerly BMJ Informatica) no longer licence our QCancer software development kit. We therefore no longer recommend their implementation of QCancer (if indeed they are still marketing one).